Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pancreatic neuroendocrine neoplasms (pNENs) are rising. Endoscopic ultrasound-guided ablative therapies show promise for selected pNENs, but more evidence is needed for widespread use.
Area Of Science
- Gastroenterology and Oncology
- Minimally Invasive Procedures
Background
- Pancreatic neuroendocrine neoplasms (pNENs) are increasing, accounting for 2% of pancreatic tumors.
- Manifestations vary from hormone syndromes to metastasis; treatment depends on tumor grade and size.
- Surgery is standard for aggressive tumors, while indolent tumors may be monitored.
Purpose Of The Study
- To review current endoscopic ultrasound (EUS)-guided locoregional therapies for pNENs.
- To outline patient selection, procedural details, and risks of these emerging treatments.
Main Methods
- Review of current literature on EUS-guided ablative techniques (ethanol injection, radiofrequency ablation) for pNENs.
- Analysis of safety, efficacy, and patient selection criteria.
Main Results
- EUS-guided ablative techniques show a promising safety profile and efficacy for selected pNEN cases.
- These minimally invasive options offer alternatives for loco-regional treatment.
Conclusions
- EUS-guided therapies represent a promising advancement in pNEN management.
- High-quality evidence is required to support broader clinical adoption of these techniques.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
